MAGEA3 and neoplasm: DC-derived EVs are able to stimulate tumor-specific immune responses when loaded with TAAs (e.g., melanoma-associated antigen 3-MAGE-A3, alpha-fetoprotein-AFP) or IFN-γ [187,210,211].